You just read:

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

News provided by

Takeda Pharmaceutical Company Limited

05 Jun, 2015, 22:35 BST